Basel, Switzerland, 21 October 2014 – Lonza is pleased to provide some guidance on the use of its
portfolio of disinfectants and disinfectant cleaners as part of an infection
control program for the Ebola virus.
On 1 August
2014, the U.S. Centers for Disease Control and Prevention (CDC) released
guidance titled “Infection Prevention and Control Recommendations for
Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S.
states in part: “Ebola viruses are transmitted through direct contact with
blood or body fluids/substances (e.g., urine, feces, vomit) of an infected
person with symptoms or through exposure to objects (such as needles) that have
been contaminated with infected blood or body fluids. The role of the
environment in transmission has not been established”.
continues to say that, as part of the program of care of persons with probable
or confirmed Ebola virus infections, hospitals are recommended to “Use a U.S.
Environmental Protection Agency (EPA)-registered hospital disinfectant with a
label claim for a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus,
poliovirus) to disinfect environmental surfaces in rooms of patients with
suspected or confirmed Ebola virus infection”.
and in specific reference to “Environmental infection control”, the CDC has
stated “Appropriate disinfectants for Ebola virus and other filoviruses
include…hospital-grade quaternary ammonium…products”2
addition, within Europe, the current EN 14885:2006 standard “Application of
European Standards for Chemical Disinfectants and Antiseptics” stipulates that
for a “virucidal” claim to be made for hard surface and instrument
disinfectants, efficacy against poliovirus and adenovirus needs to be
demonstrated using the EN 14476:2005 test protocol.
a leading global manufacturer of disinfectants and disinfectant cleaners, many
with supported label claims for viruses including those identified by U.S. CDC
and within EN 14885:2006. Lonza offers for sale disinfectants with specific
claims against target organisms as approved for the jurisdiction in which each
product is sold.
within Lonza’s U.S. portfolio are several product families that meet the CDC
guidance to use products having efficacy against non-enveloped viruses
including Bardac® 205M, Lonzagard® HWS, Lonzagard® R-82, Lonzagard® RCS and
Lonzagard® Disinfectant Wipes. In Europe, Lonzagard® DR-25aN Disinfectant
Cleaner can make “virucidal” claims according to standards set by EN
also offers HTH® Calcium Hypochlorite, a multi-purpose disinfectant and sanitizer.
Chlorine products are widely recognized and recommended by international health
authorities and used by non-governmental organizations. HTH® Calcium
Hypochlorite has been registered for the sanitation of drinking and waste water
and for the disinfection of hard surfaces, vehicles and containers, among other
further information, please find a list of your local regional contacts: